These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 17372025)

  • 41. Phl p 1-specific human monoclonal IgE and design of a hypoallergenic group 1 grass pollen allergen fragment.
    Levin M; Rydnert F; Källström E; Tan LW; Wormald PJ; Lindstedt M; Greiff L; Ohlin M
    J Immunol; 2013 Jul; 191(2):551-60. PubMed ID: 23761636
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Interference of
    López-Freire S; Méndez-Brea P; González-Fernández T; Gude F; Vidal C
    Eur Ann Allergy Clin Immunol; 2021 Jul; 53(4):185-190. PubMed ID: 32549528
    [No Abstract]   [Full Text] [Related]  

  • 43. Intradermal Phleum pratense allergoid immunotherapy. Double-blind, randomized, placebo-controlled trial.
    Sola Martínez FJ; Barranco Jiménez RM; Martín García C; Senent Sánchez C; Blanco Guerra C; Fernández-Rivas M; Vega Castro A; Dávila González I; Carbonell Martínez A; Panizo Bravo C; Gómez Torrijos E; Rodríguez Gil D; Palacios Peláez R
    Clin Exp Allergy; 2020 Dec; 50(12):1352-1361. PubMed ID: 32946612
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Immunologic effects and tolerability profile of in-season initiation of a standardized-quality grass allergy immunotherapy tablet: a phase III, multicenter, randomized, double-blind, placebo-controlled trial in adults with grass pollen-induced rhinoconjunctivitis.
    Reich K; Gessner C; Kroker A; Schwab JA; Pohl W; Villesen H; Wüstenberg E; Emminger W
    Clin Ther; 2011 Jul; 33(7):828-40. PubMed ID: 21741092
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Specific immune response to Phleum pratense plant profilin in atopic patients and control subjects.
    Benítez D; García-Ortega P; Picado C; Milà J; Vives J; Martínez J; Vilella R
    Allergol Immunopathol (Madr); 2001; 29(1):9-15. PubMed ID: 11449535
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Purification, structural and immunological characterization of a timothy grass (Phleum pratense) pollen allergen, Phl p 4, with cross-reactive potential.
    Stumvoll S; Lidholm J; Thunberg R; DeWitt AM; Eibensteiner P; Swoboda I; Bugajska-Schretter A; Spitzauer S; Vangelista L; Kazemi-Shirazi L; Sperr WR; Valent P; Kraft D; Valenta R
    Biol Chem; 2002 Sep; 383(9):1383-96. PubMed ID: 12437131
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effect of 2 Years of Treatment With Sublingual Grass Pollen Immunotherapy on Nasal Response to Allergen Challenge at 3 Years Among Patients With Moderate to Severe Seasonal Allergic Rhinitis: The GRASS Randomized Clinical Trial.
    Scadding GW; Calderon MA; Shamji MH; Eifan AO; Penagos M; Dumitru F; Sever ML; Bahnson HT; Lawson K; Harris KM; Plough AG; Panza JL; Qin T; Lim N; Tchao NK; Togias A; Durham SR;
    JAMA; 2017 Feb; 317(6):615-625. PubMed ID: 28196255
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Grass pollen immunotherapy for hayfever is associated with increases in local nasal but not peripheral Th1:Th2 cytokine ratios.
    Wachholz PA; Nouri-Aria KT; Wilson DR; Walker SM; Verhoef A; Till SJ; Durham SR
    Immunology; 2002 Jan; 105(1):56-62. PubMed ID: 11849315
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Allergome-wide peptide microarrays enable epitope deconvolution in allergen-specific immunotherapy.
    Mikus M; Zandian A; Sjöberg R; Hamsten C; Forsström B; Andersson M; Greiff L; Uhlén M; Levin M; Nilsson P; van Hage M; Ohlin M
    J Allergy Clin Immunol; 2021 Mar; 147(3):1077-1086. PubMed ID: 32791163
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Dissection of the grass allergen-specific immune response in patients with allergies and control subjects: T-cell proliferation in patients does not correlate with specific serum IgE and skin reactivity.
    Würtzen PA; van Neerven RJ; Arnved J; Ipsen H; Sparholt SH
    J Allergy Clin Immunol; 1998 Feb; 101(2 Pt 1):241-9. PubMed ID: 9500758
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Mucosal tissue polyclonal IgE is functional in response to allergen and SEB.
    Zhang N; Holtappels G; Gevaert P; Patou J; Dhaliwal B; Gould H; Bachert C
    Allergy; 2011 Jan; 66(1):141-8. PubMed ID: 20659077
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of grass pollen immunotherapy on clinical and local immune response to nasal allergen challenge.
    Scadding GW; Eifan AO; Lao-Araya M; Penagos M; Poon SY; Steveling E; Yan R; Switzer A; Phippard D; Togias A; Shamji MH; Durham SR
    Allergy; 2015 Jun; 70(6):689-96. PubMed ID: 25773990
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Sublingual immunotherapy in children modulates allergen-induced in vitro expression of cytokine mRNA in PBMC.
    Savolainen J; Jacobsen L; Valovirta E
    Allergy; 2006 Oct; 61(10):1184-90. PubMed ID: 16942566
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Synchronous immune alterations mirror clinical response during allergen immunotherapy.
    Renand A; Shamji MH; Harris KM; Qin T; Wambre E; Scadding GW; Wurtzen PA; Till SJ; Togias A; Nepom GT; Kwok WW; Durham SR
    J Allergy Clin Immunol; 2018 May; 141(5):1750-1760.e1. PubMed ID: 29128670
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Immunological changes during specific immunotherapy of grass pollen allergy: reduced lymphoproliferative responses to allergen and shift from TH2 to TH1 in T-cell clones specific for Phl p 1, a major grass pollen allergen.
    Ebner C; Siemann U; Bohle B; Willheim M; Wiedermann U; Schenk S; Klotz F; Ebner H; Kraft D; Scheiner O
    Clin Exp Allergy; 1997 Sep; 27(9):1007-15. PubMed ID: 9678832
    [TBL] [Abstract][Full Text] [Related]  

  • 56. IgE antibodies to recombinant pollen allergens (Phl p 1, Phl p 2, Phl p 5, and Bet v 2) account for a high percentage of grass pollen-specific IgE.
    Niederberger V; Laffer S; Fröschl R; Kraft D; Rumpold H; Kapiotis S; Valenta R; Spitzauer S
    J Allergy Clin Immunol; 1998 Feb; 101(2 Pt 1):258-64. PubMed ID: 9500760
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Characterization of mutants of a highly cross-reactive calcium-binding protein from Brassica pollen for allergen-specific immunotherapy.
    Garmatiuk T; Swoboda I; Twardosz-Kropfmüller A; Dall'Antonia F; Keller W; Singh MB; Bhalla PL; Okada T; Toriyama K; Weber M; Ghannadan M; Sperr WR; Blatt K; Valent P; Klein B; Niederberger V; Curin M; Balic N; Spitzauer S; Valenta R
    Immunobiology; 2013 Sep; 218(9):1155-1165. PubMed ID: 23790497
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Reducing allergenicity by altering allergen fold: a mosaic protein of Phl p 1 for allergy vaccination.
    Ball T; Linhart B; Sonneck K; Blatt K; Herrmann H; Valent P; Stoecklinger A; Lupinek C; Thalhamer J; Fedorov AA; Almo SC; Valenta R
    Allergy; 2009 Apr; 64(4):569-80. PubMed ID: 19243361
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Allergen content of grass pollen preparations for skin prick testing and sublingual immunotherapy.
    Sander I; Fleischer C; Meurer U; Brüning T; Raulf-Heimsoth M
    Allergy; 2009 Oct; 64(10):1486-1492. PubMed ID: 19385952
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Concentrations of major grass group 5 allergens in pollen grains and atmospheric particles: implications for hay fever and allergic asthma sufferers sensitized to grass pollen allergens.
    Schäppi GF; Taylor PE; Pain MC; Cameron PA; Dent AW; Staff IA; Suphioglu C
    Clin Exp Allergy; 1999 May; 29(5):633-41. PubMed ID: 10231323
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.